Blog

FDA Guidance for More Inclusive Clinical Trial Enrollment Practices

11 November 2020 by CITI Program

Clinical drug and biologics trials should aim to have participants represent the likely users of the approved medication. The FDA has issued guidance for sponsors that recommends approaches to increase enrollment of underrepresented populations in clinical trials. Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial Designs Guidance for Industry […]

OHRP’S Annotated Comparison of the Revised Common Rule and the Pre-2018 Requirements

11 November 2020 by CITI Program

OHRP has added an annotated comparison of the pre-2018 Common Rule with the 2018 regulations. On this page you’ll also find additional information about whether a pre-2018 Common Rule provision has moved to another location in the 2018 Common Rule, and where to find it. While not an official version of the revised Common Rule […]

Are you thinking about participating in vaccine research?

4 November 2020 by CITI Program

As we continue to work together to fight COVID-19, we are reminded of the importance of volunteers to serve in vaccine trials. But deciding to participate in a vaccine trial can be confusing and scary. CITI Program has adapted its “Are You Thinking About Being in a Research Study?” module and has created a new […]

Public Trust in Science with Dr. Fauci

20 October 2020 by CITI Program

On November 19, 2020 and as part of the of The Hastings Center’s series, Securing Health in a Troubled Time, Dr. Anthony Fauci, Director at the National Institute of Allergy and Infectious Diseases will participate in a virtual discussion about the public’s understanding and trust in science. Learn more and register now. CITI Program’s Public […]

Are teachers born or made?

19 October 2020 by Carole Mottaz, EdD - University of Wisconsin – River Falls, Capella University

This was one of the first questions asked of us when I started teacher training college in England a number – possibly a great number – of years ago. For most of us in my year, the former seemed to be true. But then we had all chosen to be teachers so felt we had […]

The Importance of Cybersecurity for NIH-Supported Research

20 October 2020 by CITI Program

In recognition of National Cybersecurity Awareness Month, Dr. Michael Lauer, the NIH’s Deputy Director for Extramural Research, has published some thoughts on the importance of strong cybersecurity protocols. Data breaches can threaten the integrity of research and affect the public’s trust in scientific findings which is why the protection of sensitive and confidential data for […]

2020 Nobel Prize in Chemistry Awarded for Development of Tools to Edit DNA

19 October 2020 by CITI Program

Emmanuelle Charpentier and Jennifer Doudna have won the Nobel Prize in Chemistry for their contributions to genome editing. The pair partnered in 2011 and by 2012 had published a landmark paper detailing how they could reprogram a previously unknown molecule, tracrRNA, to cut DNA molecules at pre-determined sites allowing genetic code to be rewritten. Learn […]

Examining the Ethical and Regulatory Approaches to Artificial Intelligence (AI) in Human Subjects Research

12 October 2020 by Tamiko Eto, MS, CIP - Division of Research, Kaiser Permanente

We are excited to add two new modules to our Technology, Ethics, and Regulations course: “Artificial Intelligence (AI) and Ethics in Human Subjects Research” and “Regulatory Approaches to Artificial Intelligence (AI) in Human Subjects Research.” These in-depth modules review the ethical and regulatory challenges around AI human subjects research (AI HSR). The modules are the […]

The Most Overlooked Factor in Successful Tech Transfer

5 October 2020 by CITI Program

Research conducted at universities and academic medical centers is responsible for the development of a myriad of innovative products over the years. These innovations vary from drugs such as Remicade® to new varieties of fruits such as the Honeycrisp Apple. According to the Association of University Technology Managers (AUTM), technology transfer has contributed over $865 […]

Turn Conflict Into Cooperation

10 August 2020 by LaVena Wilkin, PhD - Sullivan University

Most people learn reading, writing, and math in school. However, few of us learn how to productively manage the inevitable conflicts that show up in our lives. As a result, many of us simply are not very good at conflict management, and we are either always ready to aggressively confront the other person, or to […]

Clinic’s HIPAA Violations Result in Hacked Database and $1.5 Million Settlement

24 September 2020 by CITI Program

Hacking is a significant threat to health care data and attacks can be very costly. Recently, an orthopedic clinic serving 138,000 patients annually, paid $1,500,000 as part of a settlement agreement with the Office for Civil Rights (OCR) at the U.S. Department of Health and Human Services. The clinic was attacked by a hacker and […]

The Path to Heritable Genome Editing

18 September 2020 by CITI Program

The U.S. National Academy of Medicine, National Academy of Sciences, and the UK’s Royal Society have formed the The International Commission on the Clinical Use of Human Germline Genome Editing to provide guidance for heritable genome editing also known as Germline editing. The committee issued a report with 11 recommendations that address specific ethical and […]

Fighting Undue Foreign Influence in Research

17 September 2020 by CITI Program

The U.S. government, as well as academic leaders, are actively trying to protect their position as a global leader in research and technology. At the same time, they are committed to ensuring transparency and openness, the ingredients that have made U.S.-based research the envy of the world. After several years of internal investigations, officials at […]

Remote Contact Tracing: Free Foundational Training to stop COVID-19 Spread From Home

15 September 2020 by Joanna Drowos, DO, MPH, MBA - Florida Atlantic University

As many organizations and communities struggle to stop the spread of COVID-19, contact tracing remains an effective public health strategy in this fight. Contact tracing is a tool where interviews with those infected with COVID-19 identify others they may have exposed before becoming ill. These contacts are then monitored and advised to change their behavior […]

GDPR Class Action Lawsuits Filed for 10 Billion Euros

15 September 2020 by CITI Program

The Privacy Collective filed wrongful use of personal data class-action lawsuits against Oracle and Salesforce (Forbes 2020). The companies are accused of violating the General Data Protection Regulation (GDPR) by not getting consent from individuals for how their data would be processed, and for not securing the personal data appropriately. The GDPR aims to protect […]

Join OHRP’s 3rd Annual Exploratory Workshop on Single IRB (sIRB) Review

15 September 2020 by CITI Program

OHRP will be hosting Practical and Ethical Considerations for Single IRB Review on Thursday 17 September 2020. No registration is required and you can view the event for free on the videocast page. This workshop will cover topics such as: Quality review Local context Oversight responsibilities Opportunities and challenges presented by the sIRB mandate Using […]

Register for the Office of Minority Health’s Virtual Symposium on COVID-19

15 September 2020 by CITI Program

On Thursday, 17 September 2020, the Office of Minority Health (OMH) will be hosting a virtual symposium, Advancing the Response to COVID-19: Sharing Promising Programs and Practices for Racial and Ethnic Minority Communities. Public health leaders will discuss their organizations’ response to the pandemic. Register Now CITI Program Webinars on Research With Minority Communities Research […]

OCR Launches Resources for Mobile Health App Developers

15 September 2020 by CITI Program

The Office for Civil Rights in Action (OCR) launched the Resources for Mobile Health App Developers, replacing their previous Health App Developer Portal. It provides guidance to Mobile Health App Developers including: How HIPAA rules apply to specific scenarios where mobile health apps are used. An interactive tool to determine which federal laws may apply […]

Discrepancies Between ClinicalTrials.gov and Corresponding Publications

17 August 2020 by CITI Program

A recent study finds high rates of discordance between trial reporting on ClinicalTrials.gov and corresponding publications. Findings accentuate the need to monitor for accurate reporting. See “Consistency of trial reporting between ClinicalTrials.gov and corresponding publications: one decade after FDAAA” CITI Program’s Clinicaltrials.gov Content Protocol Registration and Results Summary Disclosure in ClinicalTrials.gov provides a video-enhanced guide […]

Managing Conflicts is a Critical Skill in the Workplace

14 August 2020 by CITI Program

Where people gather, conflict is likely to occur. Even in an age when many professionals may be working remotely, conflicts within teams can occur. Unfortunately, managers are often ill-equipped to deal with conflict effectively. Some may even exacerbate the conflict with well-intentioned, but poorly considered, interventions. Conflicts within teams are detrimental to individuals and organizations […]

OHRP’s New Subpart C Certification Form

7 August 2020 by CITI Program

OHRP now has a new Subpart C Certification Submission Form to be submitted as part of the certification request for the inclusion of prisoners in HHS conducted or supported research, in compliance with 45 CFR 46.305(c). It has been approved for use by OMB through 31 July 2023, under Control Number 0990-0473. U.S. Department of […]

FDA Issues Guidance For Clinical Research Using Cannabis

24 July 2020 by CITI Program

The FDA has issued guidance detailing the FDA’s current thinking on clinical research with cannabis and cannabis-derived compounds. It includes quality considerations, reviews key FDA regulatory concepts, and provides recommendations related to cannabis sources and THC percentage calculation. See the full guidance for more details: Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research CITI […]

OHRP’s Video on Informed Consent Available in Spanish

16 July 2020 by CITI Program

OHRP’s latest video, Informed Consent for Research: What to Expect, on their Informational Videos page, is also available in Spanish. It covers the basics of informed consent and the information that potential study participants should receive to help decide if they want to volunteer. See the “Protegiendo a los voluntarios que participan en las investigaciones” […]

The Impact of the EU’s General Data Protection Regulation (GDPR) on U.S. Higher Ed Organizations

10 July 2020 by Ann Kristin Glenster, Member of the Centre for Intellectual Property and Information Law, Faculty of Law, University of Cambridge

In February 2018, the European Union (EU) adopted the General Data Protection Regulation (GDPR), which regulates the processing of personal data in the EU. The Regulation is wide in scope and applies to higher education organizations, whether they are located inside or outside the EU if they process personal data in the EU or that […]

OHRP Issues Decision Charts for Current and Pre-2018 Requirements

9 July 2020 by CITI Program

OHRP recently posted new decision charts for the revised Common Rule (2018 Requirements) on their website. These charts are intended to help decision-makers determine if research is considered human subjects research, if exemption categories apply, if continuing review is required, if documentation of consent can be waived, and if informed consent can be waived or […]

New Online Course Provides Information on Ethical Issues and Governance Approaches for Emerging Technologies

7 July 2020 by CITI Program

Since the onset and spread of COVID-19, many communities, businesses and individuals have relied on some of the latest technologies. From telemedicine to teleconferencing to online learning, technologies have eased the challenges of working from home. The World Economic Forum has identified ten technology trends to watch during the pandemic, including digital payments, telehealth and […]

CIP Exam Preparation and Recertification Using CITI Program Content

30 June 2020 by CITI Program

Study Help for the CIP Exam As the application deadline for the Fall 2020 CIP examination approaches (14 August for the exam window of 7 September through 7 October), remember that CITI Program’s Human Subjects Research and IRB Administration courses can help you prepare. Re-review our basic modules that cover key topics for human subjects […]

New HHS Fact Sheet: COVID-19’s Impact on Minorities

10 June 2020 by CITI Program

The HHS has released HHS Initiatives to Address the Disparate Impact of COVID-19 on African Americans and Other Racial and Ethnic Minorities. It covers the following topics: Improving our Understanding of COVID-19’s Impact on Minorities Making Testing More Accessible and Afordable Making Treatment More Accessible and Afordable Tailored Guidance for Individuals & Communities Most At […]

FDA Issues New COVID-19 Guidance for IRBs and Clinical Investigators

4 June 2020 by CITI Program

In order to support response efforts to this pandemic, the FDA has issued guidance to provide non-binding recommendations regarding the key factors and procedures IRBs should consider when reviewing individual patient expanded access submissions. Learn more about these recommendations intended to assist IRBs in complying with the requirements in 21 CFR Part 56. View the […]

Technology, Ethics, and COVID-19

3 June 2020 by CITI Program

Read AI, Robots, and Ethics in the Age of COVID-19 published by MIT’s “Sloan Management Review” for an expert’s perspective on the impact of robots and artificial intelligence (AI) during this public health emergency. It covers the following topics: Attitudes towards robots and AI Adopting robots and AI as the “new normal” The importance of […]

CITI Program Contributor Kelly Willenberg Has a New Research Blog

2 June 2020 by CITI Program

Kelly Willenberg, DBA, RN, CCRP, CHRC, CHC is one of CITI Program’s expert contributors in clinical trial billing. As a respected expert in the research community, she started the “Research Beast” blog available on the Kelly Willenberg & Associates website. View “Research Beast” Blog View CITI Program’s Clinical Trial Billing Compliance Course View CITI Program’s […]

COVID-19 Trial Shows Remdesivir is Superior to Standard Treatment

26 May 2020 by CITI Program

According to the authors of a recently published article in the New England Journal of Medicine, findings from the Adaptive COVID-19 Treatment Trial, support remdesivir as the standard treatment for patients hospitalized with COVID-19 and requiring supplemental oxygen therapy. Peer-reviewed data shows remdesivir for COVID-19 improves time to recovery

CTTI Webinar – Engaging Racial and Ethnic Minority Patient Populations in COVID-19 Clinical Trials

16 June 2020 by CITI Program

At 12 PM ET on Thursday, June 18, CTTI will host Engaging Racial and Ethnic Minority Patient Populations in COVID-19 Clinical Trials. The webinar will include discussion on how to recruit and enroll diverse populations of participants more effectively. Speakers will include: Christina Brennan, Northwell Health Richard Knight, American Association of Kidney Patients Fabian Sandoval, Emmerson […]

Recovery From Advanced COVID-19 Accelerated by Remdesivir in NIH Clinical Trial

30 April 2020 by CITI Program

In an NIH clinical trial involving 1063 patients with advanced COVID-19, preliminary results indicate that those who received broad-spectrum antiviral treatment Remdesivir recovered 31% faster than those who received a placebo. More detailed results will be published in a forthcoming report. View the complete news release

Researchers Race Toward a COVID-19 Vaccine at Breakneck Speed

29 April 2020 by CITI Program

In recent weeks biotech and clinical research communities have pivoted resources toward developing vaccines against SARS-CoV-2. Teams around the world are researching various methods of vaccine development, some of which have no approved precedent in the United States. As of this writing, researchers are investigating over 90 potential vaccines. Several of these vaccines are already […]

CITI Program Author Charles Hennekens Publishes Several Articles on COVID-19 and Public Health

28 April 2020 by CITI Program

Charles Hennekens, MD, DrPH is one of the expert authors of CITI Program’s Essentials of Public Health Research course. As a respected expert on public health, he has published several articles on COVID-19 focused on public health leadership. The Emerging Pandemic of Coronavirus: The Urgent Need for Public Health Leadership COVID-19 response and communications must […]

New Questions and Answers Added to the FDA Guidance on Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency

23 April 2020 by CITI Program

FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Public Health Emergency was released in March for industry, investigators, and institutional review boards (IRBs). On April 16th, 2020 new questions and answers were added to the appendix section with new content on several topics including: Conducting remote clinician-reported outcome or performance outcome […]

NIH Begins Trial Evaluating COVID-19 Treatment Regimen

19 May 2020 by CITI Program

This clinical trial will test the safety and efficacy of a treatment regimen of the remdesivir plus the anti-inflammatory drug baricitinib for COVID-19. It is the next iteration of NIAID’s Adaptive COVID-19 Treatment Trial (ACTT), which began on February 21, 2020 and evaluated Remdesivir. In this next trial called ACTT 2, all participants will receive […]

Webinar – COVID-19: Supporting Ethical Care and Responding to Workforce Concerns in a Public Health Emergency

22 April 2020 by CITI Program

Presented by Nancy Berlinger, PhD – The Hastings Center. This webinar discusses public health duties during a public health emergency. Webinar Highlights Clarifies public health duties in relation to the duty of care during a public health emergency. Identifies ethical challenges in resource allocation (staff, stuff, space) and managing changing work conditions. Discusses responding to […]

Webinar – COVID-19 and Human Research Protection Programs

14 April 2020 by CITI Program

Presented by Brenda L. Ruotolo, BA – Columbia University; Challace D. Pahlevan-Ibrekic, MS – Columbia University. An in-depth discussion on how one institution and its HRPP responded to the COVID-19 pandemic that may help guide other organizations. Webinar Highlights Provides a detailed exploration of how a human research protection program (HRPP) responded to and has […]

NIH Study to Quantify Undetected COVID-19 Cases

13 April 2020 by CITI Program

A new NIH study will analyze blood samples from up to 10,000 volunteers without confirmed cases of COVID-19 for the presence of antibodies to the virus. It aims to provide insight into the undetected spread of the virus as well as which communities and populations are affected most. NIH begins study to quantify undetected cases […]

OHRP issues guidance on COVID-19

13 April 2020 by CITI Program

On April 8, 2020, the Office for Human Research Protections (OHRP) issued guidance on the regulatory requirements of 45 CFR 46 and actions taken during COVID-19 for the research community. Specifically, the guidance addresses public health and clinical activities, research changes to eliminate apparent immediate hazards, proposing and reviewing study changes, and whether suspensions of […]

Scale Training to Help Staff Take on Research Roles

22 April 2020 by CITI Program

Although most research is paused during the global pandemic, there are new COVID-19 research studies starting every day. During this time, organizations may need to train individuals that have asked to take on new roles, including the conduct of clinical trials. If your organization is moving staff from non-research to research roles, we can help […]

Webinar – FERPA and Online Learning in the Time of COVID-19

7 April 2020 by CITI Program

Presented by Thomas Gold, PhD – Acceleration Group, Inc.. This webinar explores how the Family Educational Rights and Privacy Act (FERPA) (20 U.S.C. § 1232g; 34 CFR 99) applies to online learning. The presenter explores student privacy issues and discusses different approaches aimed at safe learning and protecting student information. Review the learning objective and […]

Webinar – “Nuts & Bolts” of Running a Virtual IRB Meeting

16 March 2020 by CITI Program

Presented by Angela L. Bruch, PhD – Capella University. This webinar discusses the pragmatic issues of running a convened Institutional Review Board (IRB) meeting virtually. The webinar is designed for IRB Chairs and administrators and identifies best practices to ensuring adequate review of submissions and documentation of IRB determinations in a virtual meeting. Provides strategies […]

Technology Use to Manage Patient Care in the Era of COVID-19.

10 April 2020 by CITI Program

An article this week in Wired Magazine outlined how physicians and other health care providers in hospitals are using technology to manage patient care in an era of COVID-19. Using a combination of tablets, smart phones and video conferencing, physicians are conducting virtual rounds, whereby one physician moves from one patient room to another and […]

Guidance Issued on Defending Against VTC Hijacking and Zoom-bombing

7 April 2020 by CITI Program

The Cybersecurity and Infrastructure Security Agency (CISA) has published an article detailing steps to improve cybersecurity for video-teleconferencing (VTC) platforms. It also recommends several other VTC cybersecurity resources. Read FBI Releases Guidance on Defending Against VTC Hijacking and Zoom-bombing. CITI Program’s Information Privacy & Security (IPS) Courses These courses cover the principles of data protection, […]

OCR Bulletin: Civil Rights, HIPAA, and the Coronavirus Disease 2019 (COVID-19)

31 March 2020 by CITI Program

On March 28, 2020, the Health and Human Services Office for Civil Rights in Action (OCR) issued the bulletin Civil Rights, HIPAA, and the Coronavirus Disease 2019 (COVID-19) to ensure obligations are met under laws and regulations that prohibit discrimination in HHS-funded programs during the COVID-19 emergency. Compliance with HIPAA is critical during this pandemic […]

CITI Program’s Contribution to Health Literacy in Research

31 March 2020 by CITI Program

CITI Program continues to encourage the adoption of health literacy in research. Our Associate Director of Content and Education, Margaret Rankovic, is currently participating in a Multi-Regional Clinical Trials (MRCT) Center working group to help develop tools, training, and communication strategies for the IRB community on this important topic. MRCT’s Health Literacy in Clinical Research […]

Apps Being Developed to Improve Clinical Care

19 March 2020 by CITI Program

Mobile app research is growing in both medical and social-behavioral-educational fields of research. For example, bedside apps are being studied to see how they can improve consent during childbirth. It’s important that app researchers and IRBs are aware of important research issues involving mobile apps. CITI Program’s Mobile Apps and Human Subjects Research module discusses […]

Preparing for COVID-19, Impacts on Research Organizations

18 March 2020 by CITI Program

The rapidly evolving federal, state, and local policies regarding COVID-19 are impacting every walk of life in the United States and around the world. Companies, as well as academic and government researchers, have pivoted their focus on vaccines and possible treatments for the novel coronavirus. Health and research organizations are trying to keep up with […]

COVID-19 Vaccine Phase 1 Trial Begins

17 March 2020 by CITI Program

NIH is conducting a Phase 1 clinical trial of a new vaccine for COVID-19. Phase 1 research is the first clinical trial phase conducted with humans after animal (preclinical) research. The trial is being conducted at Kaiser Permanente Washington Health Research Institute, a NIH clinical trials center since 2007. Read more from the NIH CITI […]

Time to revisit your disaster plan?

11 March 2020 by CITI Program

COVID-19 dominates daily news headlines as communities and organizations evaluate policies regarding public gatherings, quarantines, and other issues. Many states, including New York and California, have declared states of emergency in order to free up budgets to prepare for what public health officials believe will be a continuing crisis. At the University of California, San […]

Research During Global Health Emergencies

9 March 2020 by CITI Program

Complying with research ethics is notably challenging during global health emergencies such as the outbreak of coronavirus disease (COVID-19). Investigators must have an ethical framework in place to address challenges created by the accelerated research that is sometimes necessary during these emergencies. Read the report Research in Global Health Emergencies published by The Nuffield Council […]

U.S. Federal Regulatory Agencies Provide Guidance for Clinical Trials in Response to COVID-19

24 March 2020 by CITI Program

As COVID-19 continues to impact research organizations and clinical sites, federal agencies are issuing guidance for clinical trials. Organizations are closing or dramatically reducing operations and on-site staff; supply chains are disrupted; and travel restrictions have left investigators, organizations, and sponsors scrambling to respond. In response, the FDA is providing guidance for those impacted. The […]

Compliance With Posting Clinical Trials Results on ClinicalTrials.gov

6 February 2020 by CITI Program

Both the journals Science and The Lancet have recently published studies showing a lack of compliance with posting clinical trials results on ClinicalTrials.gov. Be sure your research program and investigators meet these critical requirements with CITI Program’s ClinicalTrials.gov course and webinar. Course: Protocol Registration and Results Summary Disclosure in ClinicalTrials.gov Webinar: Building a ClinicalTrials.gov Compliance […]

Ethical Considerations for Replicating Bones with 3D Printing

24 January 2020 by CITI Program

Evolving technology now makes 3D printing an inexpensive technology for reproducing replica bones. Digital bone repositories around the world are currently working through the ethical issues involved with this technology, such as who owns the right to print which bones or if it is even possible to own the rights to part of a person. […]

Webcast of NAS Workshop, An Examination of Emerging Bioethical Issues in Biomedical Research

23 January 2020 by CITI Program

The National Academy of Sciences, Engineering, and Medicine will be hosting An Examination of Emerging Bioethical Issues in Biomedical Research on February 26, 2020 at 8:30 am Eastern time. The workshop will, “bring together stakeholders to discuss potential ethical issues that may arise from new and emerging trends in biomedical research (including behavioral and social […]

The Importance of Improving ClinicalTrials.gov Compliance

12 February 2020 by CITI Program

For two decades, the federal government has encouraged transparency in research. As a result of these efforts, it established ClinicalTrials.gov, a national registry of U.S. clinical trials. The objective was to improve public trust in research and to help potential participants find appropriate trials. Since then, researchers are also required to post summary results in […]

Improving Drugs Through Patient-Centric Design for Clinical Trials

9 January 2020 by CITI Program

Read about the approach to drug development that includes tolerability, ease of use, compliance with therapy, and quality of life as topics addressed along with traditional quantitative risk-benefit analysis. The author speaks to the need for new and creative solutions that address the broader needs of patients as individuals. Improving the next generation of drugs […]

OHRP Releases the 2020 Edition of the International Compilation of Human Research Standards

10 March 2020 by CITI Program

View OHRP’s 2020 edition of the International Compilation of Human Research Standards. This compilation of laws, regulations, and guidelines is helpful to CITI Program organizations that are involved in international research. The included laws, regulation, and guidelines have been classified into nine categories: General Drugs and Devices Clinical Trial Registries Research Injury Social-Behavioral Research Privacy/Data […]

Resource to Determine if Your Research Involves Human Subjects

8 January 2020 by CITI Program

The NIH Office of Extramural Research (OER) provides a decision tool to help determine if research is considered human subjects research and if it may be considered exempt from Federal regulations. This tool was recently updated to reflect the 2018 Revised Common Rule requirements. Decision Tool: Am I Doing Human Subjects Research? Did you know […]

Guidance Issued on the Application of FERPA and HIPAA to Student Health Records

3 January 2020 by CITI Program

The U.S. Departments of Health and Human Services and Education have released “Joint Guidance on the Application of the Family Educational Rights and Privacy Act (FERPA) and the Health Insurance Portability and Accountability Act of 1996 (HIPAA) to Student Health Records.” It provides guidance on each rule’s applicability and what information can be shared under […]

Revised Common Rule Now in Full Effect

22 January 2020 by CITI Program

On January 20, 2020, the sIRB requirement under the revised Common Rule went into effect. This marked the final step in the timeline for full implementation of the revised rule. sIRB Training Resources Webinar: Preparing for Single IRB (sIRB) under the Common Rule Add this webinar and have learners listen to Dr. Nichelle Cobb, the […]